Notably, our study identifies galectin-1, which is highly expressed in AML cell lines and AML primary samples, as a crucial factor in inducing CAR down-regulation and hindering the cytotoxicity of CAR T cells. Here, LGALS1 is linked to acute myeloid leukemia.